4E-BP1 is a key effector of the oncogenic activation of the AKT and ERK signaling pathways that integrates their function in tumors.

@article{She20104EBP1IA,
  title={4E-BP1 is a key effector of the oncogenic activation of the AKT and ERK signaling pathways that integrates their function in tumors.},
  author={Q. She and Ensar Halilovic and Q. Ye and W. Zhen and S. Shirasawa and T. Sasazuki and D. Solit and N. Rosen},
  journal={Cancer cell},
  year={2010},
  volume={18 1},
  pages={
          39-51
        }
}
PIK3CA and PTEN alterations are common in human cancer, but only a fraction of such tumors are dependent upon AKT signaling. AKT independence is associated with redundant activation of cap-dependent translation mediated by convergent regulation of the translational repressor 4E-BP1 by the AKT and ERK pathways. This provides mechanistic bases for the limited activity of AKT and MEK inhibitors in tumors with comutation of both pathways and the profound synergy observed with combined inhibition… Expand
S6K1 and 4E-BP1 Are Independent Regulated and Control Cellular Growth in Bladder Cancer
New insights into 4E-BP1-regulated translation in cancer progression and metastasis.
AKT as a Therapeutic Target for Cancer.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 51 REFERENCES
Genetic inactivation of AKT1, AKT2, and PDPK1 in human colorectal cancer cells clarifies their roles in tumor growth regulation
Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer.
Breast Tumor Cells with PI3K Mutation or HER2 Amplification Are Selectively Addicted to Akt Signaling
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance.
Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex
4E-binding protein 1: a key molecular "funnel factor" in human cancer with clinical implications.
The Extracellular Signal-regulated Kinase Pathway Regulates the Phosphorylation of 4E-BP1 at Multiple Sites*
Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy
...
1
2
3
4
5
...